Unibest
← Back to patent-cliff list

CAS 14257-69-3

(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol

Codes: NACE-002

Application context (from source-drug indications)

Crohn's diseaseN-acetylglucosamineSolid tumourN-acetylglucosamineHepatocellular carcinomaN-acetylglucosamine严重急性营养不良N-acetylglucosamineIrritable bowel syndromeN-acetylglucosamine

Source drugs (routes using this intermediate)

DrugTierExpiry
N-acetylglucosamineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

N-acetylglucosamineOriginator routesteps: 2total yield: 42.6 g
(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol hydrochloride→(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.